Calendario de promoción Biomind Labs Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa Biomind Labs Inc.
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. más detalles| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 0.3737 |
| Сайт | https://www.biomindlabs.com |
| Цена ао | 0.7 |
| Cambio de precio por día: | 0% (0.7) |
|---|---|
| Cambio de precio por semana.: | 0% (0.7) |
| Cambio de precio por mes: | 0% (0.7) |
| Cambio de precio en 3 meses.: | +127.57% (0.3076) |
| Cambio de precio en seis meses: | +40% (0.5) |
| Cambio de precio por año: | +105.88% (0.34) |
| Cambio de precio en 3 años.: | -30.69% (1.01) |
| Cambio de precio desde principios de año.: | +127.57% (0.3076) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Mr. Alejandro Antalich | CEO & Director | 1974 (51 año) | |
| Mr. Oscar Alejandro Leon | CFO & Director | 1960 (65 años) | |
| Ms. Paola Diaz Dellavalle Ph.D. | Chief Scientific Officer | ||
| Mr. Juan Presa | Chief Legal Officer | ||
| Ms. Magdalena Alvarez M.A. | Head of Communication | ||
| Mr. Martin Daners | Head of Quality Assurance & Regulatory Affairs |
DIRECCIÓN: Uruguay, Canelones, Building Ceibo Of. 002 - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.biomindlabs.com
Sitio web: https://www.biomindlabs.com
